Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.

Iyengar SS, Nair T, Hiremath JS, Jadhav U, Katyal VK, Kumbla D, Sathyamurthy I, Jain RK, Srinivasan M.

Indian Heart J. 2013 Jul-Aug;65(4):436-41. doi: 10.1016/j.ihj.2013.06.010.

2.

Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian Registry.

Iyengar SS, Nair T, Hiremath JS, Jadhav U, Katyal VK, Kumbla D, Sathyamurthy I, Jain RK, Srinivasan M, Sahooo PK, Chawla K.

Indian Heart J. 2011 Jan-Feb;63(1):104-7.

PMID:
23189874
3.

Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian Registry.

Iyengar SS, Nair T, Sathyamurthy I, Hiremath JS, Jadhav U, Kumbla D, Jain RK, Srinivasan M, Sahoo PK, Chawla K, Katiyal VK.

Indian Heart J. 2009 Sep-Oct;61(5):480-1.

PMID:
20635768
4.

Efficacy and safety of tenecteplase in Indian elderly STEMI patients from the Elaxim Indian Registry.

Sathyamurthy I, Bahuleyan CG, Srinivas A, Gadkari M, Kumar S, Ratnaparkhi G, Mahurkar U.

Indian Heart J. 2011 May-Jun;63(3):234-6.

PMID:
22734341
5.

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).

Singh RK, Trailokya A, Naik MM.

J Assoc Physicians India. 2015 Apr;63(4):30, 32-5.

PMID:
26591167
6.

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.

Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, Greenberg S, Miller J, Kitt MM, Strony J, McCabe CH, Braunwald E, Califf RM; INTEGRITI Investigators..

J Am Coll Cardiol. 2003 Apr 16;41(8):1251-60.

7.

Efficacy and safety of tenecteplase in Indian patients with st-segment elevation myocardial infarction.

Sathyamurthy I, Srinivasan KN, Jayanthi K, Vaidiyanathan D, Prabhakar D, Ramachandran P.

Indian Heart J. 2008 Nov-Dec;60(6):554-7.

PMID:
19276495
8.

Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.

Armstrong PW, Zheng Y, Westerhout CM, Rosell-Ortiz F, Sinnaeve P, Lambert Y, Lopes RD, Bluhmki E, Danays T, Van de Werf F; STREAM investigators..

Am Heart J. 2015 Jun;169(6):890-898.e1. doi: 10.1016/j.ahj.2015.03.011.

PMID:
26027628
9.
11.

[An angiographic trial to evaluate the efficacy and safety of tenecteplase in Chinese patients with acute myocardial infarction].

Liang F, Wang LZ, Hu DY, Shi XB, Wei JP, Zhao H, Wang L, Jia SQ, Wang HY, Liu RH, Chen YD, Lu YL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jun;37(6):514-7. Chinese.

PMID:
19927632
12.

Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural EMS system.

Crowder JS, Hubble MW, Gandhi S, McGinnis H, Zelman S, Bozeman W, Winslow J.

Prehosp Emerg Care. 2011 Oct-Dec;15(4):499-505. doi: 10.3109/10903127.2011.598609.

PMID:
21815730
13.

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.

Van de Werf F, Cannon CP, Luyten A, Houbracken K, McCabe CH, Berioli S, Bluhmki E, Sarelin H, Wang-Clow F, Fox NL, Braunwald E.

Am Heart J. 1999 May;137(5):786-91.

PMID:
10220625
14.

Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA).

Gibson CM, Marble SJ.

Clin Cardiol. 2001 Sep;24(9):577-84. Review.

17.

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

Van de Werf F, Barron HV, Armstrong PW, Granger CB, Berioli S, Barbash G, Pehrsson K, Verheugt FW, Meyer J, Betriu A, Califf RM, Li X, Fox NL; ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic..

Eur Heart J. 2001 Dec;22(24):2253-61.

PMID:
11728145
18.

Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI - Indian registry data.

Sathyamurthy I, Jayanthi K, Iyengar SS, Hiremath JS, Kumbla D, Ramesh B.

J Assoc Physicians India. 2010 Apr;58:229-30. No abstract available.

PMID:
21046876
19.
20.

Supplemental Content

Support Center